Methylprednisolone 100 mg tablet formulation with pea protein: experimental approaches over intestinal permeability and cytotoxicity.

Koc, Erhan; Ciftci, Fatih; Calik, Hilal; Korkmaz, Seval; Koc, Rabia Cakir

Koc, Erhan; Ciftci, Fatih; Calik, Hilal; Korkmaz, Seval; Koc, Rabia Cakir.

Afiliação

Koc E; Department of Bioengineering, Yildiz Technical University, Istanbul, Turkey.
Ciftci F; Department of Biomedical Engineering, Fatih Sultan Mehmet Vakif University, Istanbul, Turkey.
Calik H; Department of Technology Transfer Office, Fatih Sultan Mehmet Vakif University, Istanbul, Turkey.
Korkmaz S; Department of Bioengineering, Yildiz Technical University, Istanbul, Turkey.
Koc RC; Department of Pharmacology, Biruni University, Istanbul, Turkey.

Drug Dev Ind Pharm ; 49(7): 467-478, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37421633

Assuntos

Proteínas de Ervilha; Humanos; Animais; Camundongos; Células CACO-2; Comprimidos; Permeabilidade; Metilprednisolona/farmacologia; Solubilidade

Palavras-chave

Caco-2; DoE; Methylprednisolone; cytotoxicity; factorial design; formulation; quality by design; spray dry

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Ervilha Limite: Animals / Humans Idioma: En Revista: Drug Dev Ind Pharm Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google